Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of acetazolamide on the incidence of high altitude pulmonary edema at 4559 m
2017-005166-22Phase 2Completed
- Sponsor
- DGAI
- Start
- Feb 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of acetazolamide in high altitude pulmonary edema (HAPE), high altitude illness, sponsored by DGAI. Started Feb 2018; status: completed.
02
Drugs
acetazolamide
03
Conditions
high altitude pulmonary edema (HAPE)high altitude illness
Beyond the preview
Go deeper on 2017-005166-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-005166-22.